MCID: VSC007
MIFTS: 65

Vascular Disease

Categories: Mental diseases, Gastrointestinal diseases, Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Vascular Disease

Summaries for Vascular Disease

MedlinePlus : 41 the vascular system is the body's network of blood vessels. it includes the arteries, veins and capillaries that carry blood to and from the heart. problems of the vascular system are common and can be serious. arteries can become thick and stiff, a problem called atherosclerosis. blood clots can clog vessels and block blood flow to the heart or brain. weakened blood vessels can burst, causing bleeding inside the body. you are more likely to have vascular disease as you get older. other factors that make vascular disease more likely include family history of vascular or heart diseases pregnancy illness or injury long periods of sitting or standing still any condition that affects the heart and blood vessels, such as diabetes or high cholesterol smoking obesity losing weight, eating healthy foods, being active and not smoking can help vascular disease. other treatments include medicines and surgery.

MalaCards based summary : Vascular Disease, also known as vascular diseases, is related to adams-oliver syndrome 5 and capillary hemangioma, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Vascular Disease is MTHFR (Methylenetetrahydrofolate Reductase), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Glucose / Energy Metabolism. The drugs Ethanol and Heparin have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and kidney, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart.

Wikipedia : 72 Vascular disease is a class of diseases of the blood vessels – the arteries and veins of the circulatory... more...

Related Diseases for Vascular Disease

Diseases related to Vascular Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 401)
id Related Disease Score Top Affiliating Genes
1 adams-oliver syndrome 5 32.6 ACE CRP VWF
2 capillary hemangioma 32.6 EDN1 MTHFR NOS3 SERPINE1
3 priapism 32.1 APOE CBS CCL2 MTHFR NOS3 PON1
4 arthritis 31.3 ACE APOE PON1
5 renovascular hypertension 30.8 EDN1 NOS3 VCAM1
6 ischemic heart disease 30.6 ACE CRP SELP SERPINE1 VEGFA VWF
7 aortopulmonary window 30.6 ACE EDN1 NOS3
8 renal fibrosis 30.4 ACE EDN1 NOS3 VEGFA VWF
9 angina pectoris 30.4 ACE APOB CRP SELE SELP SERPINE1
10 myocardial infarction 29.8 ACE ADIPOQ APOB APOE CBS CCL2
11 peripheral artery disease 29.6 ACE ADIPOQ APOB APOE CCL2 CRP
12 peripheral vascular disease 12.3
13 fibro-adipose vascular anomaly 12.2
14 hepatic vascular disease 12.1
15 retinal vascular disease 11.9
16 sternal cyst vascular anomalies 11.8
17 polyneuropathy in collagen vascular disease 11.7
18 conjunctival vascular disease 11.7
19 male genital organ vascular disease 11.7
20 buerger disease 11.2
21 hypertonia 11.2 MTHFR NOS3 VEGFA
22 pars planitis 11.2 ACE APOE MTHFR
23 autoimmune hemolytic anemia, warm type 11.2 ACE APOE
24 arteriosclerosis 11.2
25 homologous wasting disease 11.2 CBS CRP MTHFR
26 spermatogenic failure 14 11.2 APOB CRP MTHFR
27 arcus senilis 11.2 CRP MTHFR SERPINE1
28 xk aprosencephaly 11.2 APOB APOE
29 hepatocellular adenoma 11.2 ACE CRP MTHFR NOS3
30 coronary sinus stenosis 11.2 MTHFR SERPINE1
31 optic nerve neoplasm 11.2 NOS3 SELP SERPINE1
32 chronic fungal otitis externa 11.2 CRP INS
33 iron metabolism disease 11.1 ACE APOE CRP SELP
34 dysgammaglobulinemia 11.1 MTHFR SELP SERPINE1
35 listeriosis 11.1 ACE ADIPOQ VWF
36 parasitic helminthiasis infectious disease 11.1 ACE CRP SELP
37 hypercholesterolemia, due to ligand-defective apo b 11.1 APOB APOE
38 chronic diarrhea due to guanylate cyclase 2c overactivity 11.1 ACE CRP SERPINE1 VWF
39 hypomagnesemia 3, renal 11.1 ADIPOQ INS SERPINE1
40 chondrocalcinosis with early-onset osteoarthritis 11.1 APOB APOE INS PON1
41 lethal congenital contractural syndrome 2 11.1 EDN1 NOS3 VEGFA
42 elejalde disease 11.1 MTHFR NOS3 SELE SERPINE1
43 acute apical periodontitis 11.1 APOB APOE INS SERPINE1
44 hypertrichosis of eyelid 11.1 ACE CCL2 MTHFR
45 scleredema adultorum 11.1 ADIPOQ SELP VCAM1
46 traumatic glaucoma 11.1 EDN1 IGFBP1 NOS3
47 pontocerebellar hypoplasia 11.1 APOB APOE INS
48 pregnancy loss, recurrent 2 11.1 CBS MTHFR SERPINE1 VWF
49 exostosis 11.1 APOB IGFBP1 INS SERPINE1
50 ovarian insufficiency, familial 11.1 MTHFR SERPINE1 VEGFA

Comorbidity relations with Vascular Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Heart Disease
Hypertension, Essential Ischemic Heart Disease
Peripheral Vascular Disease

Graphical network of the top 20 diseases related to Vascular Disease:



Diseases related to Vascular Disease

Symptoms & Phenotypes for Vascular Disease

UMLS symptoms related to Vascular Disease:


angina pectoris, chest pain, edema, flushing, leg cramps, warm skin, vein pain

MGI Mouse Phenotypes related to Vascular Disease:

44 (show all 12)
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.41 EDN1 INS NOS3 PON1 SELE SELP
2 homeostasis/metabolism MP:0005376 10.36 INS MTHFR NOS3 PON1 SELE SELP
3 growth/size/body region MP:0005378 10.32 SELP SERPINE1 VCAM1 VEGFA ACE ACVRL1
4 immune system MP:0005387 10.28 ACE ADIPOQ APOB APOE CCL2 CRP
5 cellular MP:0005384 10.27 APOB APOE IGFBP1 INS NOS3 PON1
6 hematopoietic system MP:0005397 10.23 VCAM1 VEGFA VWF ACE ACVRL1 ADIPOQ
7 mortality/aging MP:0010768 10.2 ACE ACVRL1 ADIPOQ APOB APOE EDN1
8 liver/biliary system MP:0005370 10.15 ACE ACVRL1 ADIPOQ APOB APOE IGFBP1
9 muscle MP:0005369 9.86 ACVRL1 ADIPOQ APOB APOE EDN1 INS
10 renal/urinary system MP:0005367 9.85 ACE ACVRL1 ADIPOQ APOE EDN1 INS
11 respiratory system MP:0005388 9.56 VEGFA ACVRL1 ADIPOQ APOE NOS3 SELE
12 vision/eye MP:0005391 9.23 APOB APOE INS MTHFR NOS3 SELE

Drugs & Therapeutics for Vascular Disease

Drugs for Vascular Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1223)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 64-17-5 702
2
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6 772 46507594
3
Dopamine Approved Phase 4,Phase 3,Phase 1 51-61-6, 62-31-7 681
4
Clonidine Approved Phase 4,Phase 2,Phase 1,Early Phase 1 4205-90-7 2803
5
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 10102-43-9 145068
6
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 50-02-2 5743
7
Glyburide Approved Phase 4,Phase 3 10238-21-8 3488
8
Rosiglitazone Approved, Investigational Phase 4,Phase 3 122320-73-4 77999
9
Ezetimibe Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 163222-33-1 150311
10
Pravastatin Approved Phase 4,Phase 3,Phase 2 81093-37-0 54687
11
Pioglitazone Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 111025-46-8 4829
12
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
13
Zinc Approved Phase 4,Phase 3,Phase 1 7440-66-6 32051 23994
14
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2 57-83-0 5994
15
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2 58-22-0 6013
16
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
17
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-28-2 5757
18
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 33069-62-4 36314
19
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
20
Midazolam Approved, Illicit Phase 4,Phase 3,Phase 2,Phase 1 59467-70-8 4192
21
Nicardipine Approved Phase 4,Phase 3,Phase 2,Early Phase 1 55985-32-5 4474
22
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
23
Fluvastatin Approved Phase 4,Phase 3 93957-54-1 1548972
24
Dipyridamole Approved Phase 4,Phase 3,Phase 2,Phase 1 58-32-2 3108
25
Furosemide Approved, Vet_approved Phase 4,Phase 3,Phase 2 54-31-9 3440
26
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 24280-93-1 446541
27
Phenobarbital Approved Phase 4 50-06-6 4763
28
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128794-94-5 5281078
29
Pantoprazole Approved Phase 4,Phase 3,Phase 1 102625-70-7 4679
30
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 73590-58-6 4594
31
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 57-27-2 5288826
32
Celecoxib Approved, Investigational Phase 4,Phase 3 169590-42-5 2662
33
Metformin Approved Phase 4,Phase 3,Phase 2 657-24-9 14219 4091
34
Prazosin Approved Phase 4,Phase 1 19216-56-9 4893
35
Nitrendipine Approved Phase 4,Phase 3,Phase 2 39562-70-4 4507
36
Nifedipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 21829-25-4 4485
37
Enalapril Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 75847-73-3 5362032 40466924
38
Captopril Approved Phase 4,Phase 1,Phase 2,Early Phase 1 62571-86-2 44093
39
Lisinopril Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 83915-83-7, 76547-98-3 5362119
40
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
41
Perindopril Approved Phase 4,Phase 3,Phase 2 107133-36-8, 82834-16-0 107807
42
Enalaprilat Approved Phase 4,Phase 3,Phase 2,Phase 1 76420-72-9 6917719
43
Losartan Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 114798-26-4 3961
44
Spironolactone Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1952-01-7, 52-01-7 5833
45
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137862-53-4 60846
46
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-93-5 3639
47
Candesartan Approved Phase 4,Phase 3,Phase 2,Phase 1 139481-59-7 2541
48
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 144701-48-4 65999
49
Amlodipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 88150-42-9 2162
50
Indapamide Approved Phase 4,Phase 3 26807-65-8 3702

Interventional clinical trials:

(show top 50) (show all 10000)

id Name Status NCT ID Phase Drugs
1 Testosterone for Peripheral Vascular Disease Unknown status NCT00504712 Phase 4 Testosterone;0.9% saline
2 Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) Unknown status NCT02092532 Phase 4 Rescue Intravitreal Aflibercept Injection
3 Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy Unknown status NCT02072408 Phase 4 aflibercept
4 Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease Unknown status NCT00986752 Phase 4
5 Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery Unknown status NCT01083394 Phase 4
6 Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery Unknown status NCT01147419 Phase 4
7 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) Unknown status NCT01173094 Phase 4
8 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) Unknown status NCT01171703 Phase 4
9 Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy Unknown status NCT01743014 Phase 4 Ramipril;Clopidogrel
10 Early Warning and Optimization Strategy in Carotid Endarterectomy Unknown status NCT01210937 Phase 4
11 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4 Ginkgo Biloba Extract (GBE)
12 Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia Unknown status NCT00978159 Phase 4 esomeprazole;Famotidine
13 LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients Unknown status NCT02077257 Phase 4 Rosuvastatin
14 Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human Unknown status NCT01069042 Phase 4 Enalapril
15 The Amputation Surgical Site Infection Trial (ASSIT) Unknown status NCT02018094 Phase 4 Co-amoxiclav;Iodine;Metronidazole;Chlorhexidine;Teicoplanin;Clindamycin
16 How Bone is Made in Children Receiving Dialysis Unknown status NCT01799317 Phase 4 Vitamin D2
17 Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis Unknown status NCT00640731 Phase 4
18 Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Unknown status NCT01245998 Phase 4 Dalteparin;Dalteparin
19 Lovaza Mechanisms of Action Unknown status NCT01301794 Phase 4
20 Residual Platelet Activity In Advanced Peripheral Artery Disease Unknown status NCT01627431 Phase 4 Acetylsalicylic acid;Clopidogrel
21 Platelets Induced Vasodilation, in Vitro and in Vivo Study Unknown status NCT00152646 Phase 4 placebo, aspirine, clopidogrel
22 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
23 Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis Unknown status NCT02033135 Phase 4
24 Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events Unknown status NCT00886574 Phase 4 Cilostazol;Aspirin
25 Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Unknown status NCT01023373 Phase 4 Medical treatment
26 Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD Unknown status NCT02008786 Phase 4 ramipril;rosuvastatin;placebo
27 COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent Unknown status NCT00920283 Phase 4
28 Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Unknown status NCT01768585 Phase 4 Ivabradine;Placebo
29 Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease Unknown status NCT00144937 Phase 4 Stepwise therapy for dyslipidemia, hypertension and diabetes
30 The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Unknown status NCT01325818 Phase 4 pravastatin, rosuvastatin
31 Targeting Microvascular Dysfunction in Young Hypertensive Patients Unknown status NCT01047423 Phase 4 Simvastatin;Placebo
32 Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension Unknown status NCT01308983 Phase 4 Amiloride
33 Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings Unknown status NCT01793194 Phase 4
34 Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients Unknown status NCT01011660 Phase 4 Amlodipine, Telmisartan, Amiloride Compound , Simvastatin
35 Treatment of HYpertension: Morning Versus Evening Unknown status NCT02214498 Phase 4 Enalapril/hydrochlorothiazide;Placebo
36 Resistant Hypertension Optimal Treatment Unknown status NCT01643434 Phase 4 Spironolactone;Clonidine
37 Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome Unknown status NCT01271374 Phase 4 amlodipine and olmesartan;losartan and HCTZ
38 Hypertension Control Based on Home Blood Pressure Unknown status NCT00198562 Phase 4 Amlodipine, Losartan
39 Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension Unknown status NCT01472796 Phase 4 Tekturna(Aliskiren) plus placebo
40 BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study) Unknown status NCT02398929 Phase 4 Bisoprolol 2.5 mg;Placebo
41 INTERVENCION Trial Unknown status NCT02373163 Phase 4 Hydrochlorothiazide;Amlodipine;Telmisartan
42 Comparison of Single and Combination Diuretics in Low-Renin Hypertension Unknown status NCT02351973 Phase 4 Hydrochlorthiazide;Amiloride;Hydrochlorthiazide and Amiloride
43 The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy Unknown status NCT02231788 Phase 4 Telminuvo®Tab. 40/2.5mg;Telmitrend®Tab. 80mg
44 Treatment of Hypertension in Tibetan Adult Population Unknown status NCT02217852 Phase 4 Nitrendipine;Hydrochlorothiazide;Captopril,Hydrochlorothiazide;Beijing hypotensive No.0
45 The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension Unknown status NCT02156024 Phase 4 Gastrodia and Uncaria Drink
46 The Hypotensive Effect of Metformin in Hypertensive Patients. Unknown status NCT02072382 Phase 4 Metformin;Placebo
47 Comparative Study of the Effects of Telmisartan and Nebivolol Unknown status NCT02057328 Phase 4 TELMISARTAN;NEBIVOLOL
48 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4 herbal drug;placebo
49 Compared Efficacy and Tolerance of Two Vasopressors Used to Treat Preoperative Hypotension During Carotid Surgery Unknown status NCT01794273 Phase 4 ephedrine and phenylephrine
50 Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension Unknown status NCT01519635 Phase 4 Aliskiren;Hydrochlorothiazide

Search NIH Clinical Center for Vascular Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: aneurysm

Genetic Tests for Vascular Disease

Anatomical Context for Vascular Disease

MalaCards organs/tissues related to Vascular Disease:

39
Heart, Endothelial, Kidney, Testes, Liver, Lung, Bone

Publications for Vascular Disease

Articles related to Vascular Disease:

(show top 50) (show all 1813)
id Title Authors Year
1
Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease. ( 28851747 )
2017
2
Peripheral Vascular Disease: Treatment in Older Adults. ( 28145673 )
2017
3
Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. ( 28077689 )
2017
4
Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells. ( 27984756 )
2017
5
Restenosis in Hemodialytic Fistulas and Chronic Kidney Disease-Associated Vascular Disease: Two Pathologies Driven by Metakaryotic Stem Cells. ( 28535522 )
2017
6
Pulmonary vascular disease due to left heart disease: how to achieve a more accurate approach beyond the haemodynamic phenotype. ( 28949088 )
2017
7
A Comprehensive Approach to Hepatic Vascular Disease. ( 28430541 )
2017
8
Marrow-isolated adult multilineage inducible cells embedded within a biologically-inspired construct promote recovery in a mouse model of peripheral vascular disease. ( 28211362 )
2017
9
Social, demographic and clinical characteristics of patients suffering from peripheral vascular disease treated surgically compared to patients treated with endovascular angioplasty. ( 28905042 )
2017
10
Vascular disease: Ticagrelor not superior to clopidogrel for PAD. ( 27905478 )
2017
11
Editorial Comment on: Vascular Disease and Kidney Stones: Abdominal Aortic Calcifications Are Associated with Low Urine pH and Hypocitraturia by Patel et al. ( 28817950 )
2017
12
Insidious incrementalism: The silent failure of the microcirculation with increasing peripheral vascular disease risk. ( 28236373 )
2017
13
PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study. ( 28060188 )
2017
14
Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease. ( 27939641 )
2017
15
Wearable Sensor Technology Efficacy in Peripheral Vascular Disease (wSTEP): A Randomized Controlled Trial. ( 28498233 )
2017
16
MicroRNAs: The Swing Voters in Vascular Disease Waiting for a Program. ( 28057779 )
2017
17
The emerging role of NADPH oxidase NOX5A in vascular disease. ( 28473473 )
2017
18
Evaluation of hyperspectral imaging technology in patients with peripheral vascular disease. ( 28545710 )
2017
19
Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. ( 28859943 )
2017
20
Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease. ( 28365567 )
2017
21
Atherosclerotic vascular diseases have really the same risk factors? Comparison between large abdominal aortic aneurysm and obstructive non-coronary arterial disease. ( 28509621 )
2017
22
Gut microbiota in vascular disease: Therapeutic target? ( 28056754 )
2017
23
Microscope-Integrated Optical Coherence Tomography Angiography in the Operating Room in Young Children With Retinal Vascular Disease. ( 28384676 )
2017
24
Perivascular adipose tissue inflammation in vascular disease. ( 28063251 )
2017
25
Cerebral pseudo-tumoral neuro-Behcet: Histological demonstration of an inflammatory and vascular disease. ( 28843707 )
2017
26
Non-Atherosclerotic Vascular Disease in Women. ( 28913687 )
2017
27
Do photoreceptor cells cause the development of retinal vascular disease? ( 28438678 )
2017
28
Polyarteritis nodosa presenting as peripheral vascular disease and acute limb ischemia. ( 27853042 )
2017
29
Vascular Disease Is Associated With the Expression of Genes for Intestinal Cholesterol Transport and Metabolism. ( 27841945 )
2017
30
Polyarteritis nodosa presenting as peripheral vascular disease and acute limb ischemia. ( 28397742 )
2017
31
The Role of the Profundoplasty in the Modern Management of Patient with Peripheral Vascular Disease. ( 28549963 )
2017
32
Osseointegrated Transtibial Implants in Patients with Peripheral Vascular Disease: A Multicenter Case Series of 5 Patients with 1-Year Follow-up. ( 28926380 )
2017
33
Peripheral Vascular Disease in Patients with Diabetic Foot Ulcers - An Emerging Trend: A Prospective Study from North India. ( 28598042 )
2017
34
Calcium-induced conformational changes of Thrombospondin-1 signature domain: implications for vascular disease. ( 27485292 )
2017
35
Peripheral Vascular Disease and Death in Southern European Kidney Transplant Candidates: A Competing Risk Modeling Approach: Erratum. ( 28738405 )
2017
36
In Patients with Vascular Disease, Treating Sleep Apnea Does Not Reduce the Risk of Cardiovascular Events. ( 28084709 )
2017
37
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. ( 28847206 )
2017
38
A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression. ( 28753427 )
2017
39
Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease. ( 28224925 )
2017
40
Efficacy and safety of aspirin in patients with peripheral vascular disease: An updated systematic review and meta-analysis of randomized controlled trials. ( 28403216 )
2017
41
Pulmonary artery wave propagation and reservoir function in conscious man: impact of pulmonary vascular disease, respiration and dynamic stress tests. ( 28816352 )
2017
42
Psoriasis-associated vascular disease: the role of HDL. ( 28911329 )
2017
43
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. ( 28856537 )
2017
44
Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study. ( 28904249 )
2017
45
Black patients present with more severe vascular disease and a greater burden of risk factors than white patients at time of major vascular intervention. ( 28951156 )
2017
46
The combination of stem cells and tissue engineering: an advanced strategy for blood vessels regeneration and vascular disease treatment. ( 28915929 )
2017
47
Population-based screening for vascular disease. ( 28859946 )
2017
48
The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study. ( 28065166 )
2017
49
Migraine and vascular disease biomarkers: A population-based case-control study. ( 28885052 )
2017
50
Vascular disease: Benefits of population screening for vascular risk. ( 28905862 )
2017